M
Miwon Commercial Co Ltd
KRX:002840
Miwon Commercial Co Ltd
KRX:002840
Price:
188 500
KRW
1.51%
Market Closed
Market Cap:
895.4B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Miwon Commercial Co Ltd
188500
+2800 (+1.51%)
| 52 Week Range |
163 900
213 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Miwon Commercial Co Ltd
Balance Sheet
Balance Sheet Decomposition
Miwon Commercial Co Ltd
Miwon Commercial Co Ltd
| Current Assets | 209.4B |
| Cash & Short-Term Investments | 33B |
| Receivables | 68.6B |
| Other Current Assets | 107.8B |
| Non-Current Assets | 253.1B |
| Long-Term Investments | 63.8B |
| PP&E | 182.7B |
| Intangibles | 2.3B |
| Other Non-Current Assets | 4.2B |
| Current Liabilities | 43.8B |
| Accounts Payable | 18.7B |
| Accrued Liabilities | 3.6B |
| Short-Term Debt | 291.3m |
| Other Current Liabilities | 21.2B |
| Non-Current Liabilities | 28.8B |
| Other Non-Current Liabilities | 28.8B |
Balance Sheet
Miwon Commercial Co Ltd
Miwon Commercial Co Ltd
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
5 985
|
9 253
|
20 080
|
4 830
|
23 069
|
9 195
|
22 221
|
21 671
|
25 264
|
37 422
|
|
| Cash |
5
|
7
|
0
|
10
|
6
|
6
|
5
|
8
|
4
|
2
|
|
| Cash Equivalents |
5 980
|
9 246
|
20 080
|
4 820
|
23 063
|
9 189
|
22 216
|
21 663
|
25 260
|
37 420
|
|
| Short-Term Investments |
0
|
111
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
39 369
|
41 186
|
68 341
|
60 348
|
40 402
|
49 199
|
52 726
|
64 041
|
68 618
|
62 750
|
|
| Accounts Receivables |
35 657
|
37 810
|
59 546
|
54 920
|
34 873
|
44 383
|
50 061
|
59 828
|
64 090
|
58 157
|
|
| Other Receivables |
3 712
|
3 376
|
8 795
|
5 428
|
5 529
|
4 816
|
2 665
|
4 213
|
4 528
|
4 594
|
|
| Inventory |
48 467
|
45 100
|
55 133
|
50 058
|
47 320
|
61 239
|
62 321
|
85 524
|
102 744
|
95 868
|
|
| Other Current Assets |
627
|
475
|
796
|
760
|
919
|
599
|
428
|
327
|
571
|
691
|
|
| Total Current Assets |
94 447
|
96 124
|
144 350
|
115 996
|
111 709
|
120 230
|
137 696
|
171 562
|
197 197
|
196 731
|
|
| PP&E Net |
97 751
|
87 944
|
134 313
|
118 420
|
77 879
|
109 997
|
137 233
|
142 195
|
156 827
|
186 524
|
|
| PP&E Gross |
97 751
|
87 944
|
134 313
|
118 420
|
77 879
|
109 997
|
137 233
|
142 195
|
156 827
|
186 524
|
|
| Accumulated Depreciation |
80 939
|
94 258
|
121 671
|
123 990
|
105 440
|
118 150
|
136 644
|
159 889
|
187 181
|
216 527
|
|
| Intangible Assets |
1 961
|
2 030
|
2 284
|
2 070
|
1 355
|
1 777
|
1 745
|
2 166
|
2 046
|
2 189
|
|
| Note Receivable |
2 153
|
2 275
|
2 580
|
2 489
|
1 909
|
1 302
|
1 598
|
1 852
|
2 079
|
2 923
|
|
| Long-Term Investments |
30 697
|
41 305
|
44 352
|
48 752
|
51 256
|
46 004
|
49 108
|
53 080
|
55 896
|
56 352
|
|
| Other Long-Term Assets |
1 626
|
1 516
|
1 695
|
2 377
|
1 438
|
1 383
|
1 573
|
1 557
|
1 573
|
2 846
|
|
| Total Assets |
228 635
N/A
|
231 195
+1%
|
329 574
+43%
|
290 103
-12%
|
245 547
-15%
|
280 694
+14%
|
328 955
+17%
|
372 414
+13%
|
415 619
+12%
|
447 566
+8%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
12 686
|
15 099
|
21 885
|
24 461
|
17 489
|
14 630
|
16 119
|
24 933
|
16 173
|
16 105
|
|
| Accrued Liabilities |
2 896
|
3 362
|
4 879
|
1 985
|
1 856
|
2 361
|
2 707
|
3 027
|
3 784
|
4 260
|
|
| Short-Term Debt |
29 859
|
20 981
|
22 909
|
23 112
|
283
|
532
|
696
|
430
|
614
|
549
|
|
| Current Portion of Long-Term Debt |
11 390
|
0
|
5 911
|
411
|
0
|
12
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
7 431
|
8 325
|
10 919
|
9 620
|
14 538
|
17 974
|
16 099
|
18 259
|
27 536
|
18 569
|
|
| Total Current Liabilities |
64 263
|
47 767
|
66 502
|
59 589
|
34 166
|
35 509
|
35 622
|
46 649
|
48 107
|
39 483
|
|
| Long-Term Debt |
5 500
|
5 500
|
2 892
|
5 481
|
0
|
47
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
6 034
|
5 308
|
9 404
|
6 896
|
3 091
|
7 645
|
10 278
|
12 761
|
9 013
|
8 216
|
|
| Minority Interest |
15 547
|
17 457
|
55 739
|
26 101
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
7 561
|
9 045
|
11 561
|
10 959
|
10 600
|
12 938
|
15 480
|
17 017
|
16 650
|
21 901
|
|
| Total Liabilities |
98 905
N/A
|
85 077
-14%
|
146 098
+72%
|
109 027
-25%
|
47 857
-56%
|
56 138
+17%
|
61 381
+9%
|
76 427
+25%
|
73 771
-3%
|
69 599
-6%
|
|
| Equity | |||||||||||
| Common Stock |
7 837
|
7 892
|
7 949
|
7 969
|
7 992
|
6 662
|
6 662
|
6 662
|
6 662
|
6 662
|
|
| Retained Earnings |
90 578
|
102 749
|
119 341
|
125 888
|
156 470
|
182 847
|
252 707
|
283 822
|
328 791
|
363 948
|
|
| Additional Paid In Capital |
6 019
|
8 160
|
23 230
|
22 761
|
8 140
|
33 411
|
4 984
|
4 970
|
4 825
|
4 766
|
|
| Unrealized Security Profit/Loss |
29 015
|
30 282
|
35 886
|
27 537
|
25 027
|
1 550
|
3 131
|
4 400
|
3 355
|
3 690
|
|
| Treasury Stock |
3 819
|
3 023
|
3 023
|
3 023
|
0
|
0
|
0
|
4 255
|
2 101
|
1 402
|
|
| Other Equity |
100
|
58
|
93
|
55
|
60
|
86
|
91
|
388
|
316
|
303
|
|
| Total Equity |
129 730
N/A
|
146 118
+13%
|
183 475
+26%
|
181 076
-1%
|
197 690
+9%
|
224 555
+14%
|
267 574
+19%
|
295 987
+11%
|
341 849
+15%
|
377 967
+11%
|
|
| Total Liabilities & Equity |
228 635
N/A
|
231 195
+1%
|
329 574
+43%
|
290 103
-12%
|
245 547
-15%
|
280 694
+14%
|
328 955
+17%
|
372 414
+13%
|
415 619
+12%
|
447 566
+8%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
6
|
6
|
6
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
